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Table 1
Variable N-HCM (n¼23) H-LVH (n¼11) p value
Age (years) 43.613.6 60.68.2 <0.0001*
Male/Female 15/8 7/4 0.93
LV mass (g) 368118 30059 0.077
Septal thickness (mm) 22.54.5 16.22.3 <0.0001*
Posterior wall thickness (mm) 12.42 14.41.6 0.007*
LV end-diastolic diameter (mm) 45.65.4 46.35.2 0.34
LV end-systolic diameter (mm) 26.44.2 26.54.9 0.86
Mitral E velocity (m/s) 0.760.2 0.620.13 0.063
E deceleration time (ms) 17359 22253 0.021*
Septal mitral Sa (cm/s) 7.31.9 6.91.3 0.44
Septal mitral Ea (cm/s) 5.81.6 5.71.6 0.95
Lateral mitral Sa (cm/s) 8.42.6 8.22.6 0.58
Lateral mitral Ea (cm/s) 103.6 7.22.6 0.06
E/Ea (septal) 145.4 123.1 0.42
E/Ea (lateral mitral) 8.32.7 9.62.8 0.22
Global longitudinal S (%) -11.82.6 -14.52.6 0.012*
Longitudinal ENDO S (%) -12.72.7 -15.22.5 0.023*
Longitudinal EP_I S (%) -10.92.6 -13.72.2 0.008*
Global radial S (%) 12.85.4 18.95.8 0.022*
Global circumferential S (%) -15.22.7 -15.32.5 0.59
Clinical and echocardiographic characteristics of patients (* p <0.05)
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Background: The differential diagnosis between nonobstructive hypertrophic
cardiomyopathy (N-HCM) and hypertensive hypertrophy is not always easy with
conventional echocardiography. The aim of the present study was to analyze epicar-
dial (EPI) and endocardial (ENDO) strain (S) in patients with N-HCM from
hypertensive left ventricular hypertrophy (H-LVH) using echocardiography with
2-dimensional speckle tracking imaging (2D-STI).
Methods: Conventional echocardiography, tissue Doppler imaging, and 2D-STI were
performed in 23 patients with N-HCM and 11 patients with H-LVH (New York Heart
Association functional class II and preserved ejection fraction). All echocardio-
graphic examinations were performed by iE33 and Q-lab version 8.1 (CMQ, Philips
inc). The signiﬁcance of differences between groups was evaluated by non-parametric
analysis (Mann–Whitney test).
Results: Results are summarized in table 1. Left ventricular (LV) mass and mitral
septal-lateral, systolic-diastolic annular tissue Doppler velocities were similar
among groups. ENDO and EPI longitudinal S were signiﬁcantly lower in N-HCM
when compared with H-LVH (p¼0.023, and p¼0.008, respectively). No differences
in circumferential S was found between groups.
Conclusıons: Longitudinal and radial LV deformations are impaired in patients with
N-HCM and H-LVH. Impairment of global radial strain, global longitudinal strain,
longitudinal EPI strain, and longitudinal ENDO strain is greater in N-HCM than in
H-LVH. Longitudinal ENDO and EP_I strain might be used as new additional tools for
the differentiation between N-HCM and H-LVH.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POST
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Background: Echocardiography which is commonly used as a screening test for
pulmonary hypertension may also give valuable prognostic information. Although
some recommendations are exist in guidelines, previous studies have conﬂicting
results in this issue. In this study we aimed to investigate the role of several echo-
cardiographic parameters for determining mortality and morbidity in patients with
pulmonary hypertension (PH).
Method: We enrolled the patients diagnosed with pulmonary arterial hypertension
(PAH) or chronic thromboembolic hypertension (CTEPH) that were followed up at
PAH outpatient clinic in Dokuz Eylül University Hospital. Echocardiography was
performed in all cases. Right ventricular diameter (RVd), pulmonary artery diameter,
right atrium area index (RAAi), right ventricular fractional area change (RVFAC)
tricuspid annular plane systolic excursion (TAPSE) was examined at 2D and M mod
Echo, systolic pulmonary artery pressure (sPAP), and pulmonary outﬂow tract ﬂow
velocity (PVmax) were assesed at Doppler echo, right ventricular lateral wall systolic
motion (RV lat Sm) and Rv tei index (RVtei) were examined at tissue Doppler as
continuous variables. The presence of pericardial effusion and severe of tricuspid
regurgitation (TR) were investigated as categorical variables. Death for any cause or
hospitalization due to clinical worsening was determined as a primary endpoint.
Results: A total of 72 patients (54 female, mean age: 52.718.7 years) included the
study. Mean follow up duration was 20.53 months (3-90). The distribution of patients
regarding PH type and functional class were as follows: 20 with IPAH, 24 with
congenital heart disease, 10 with connective tissue disease and 14 with CTEPH; 24
with class I,II 34 with class III and 14 with class IV. Primary end point occurred at 34
patient (25 patients died, 9 patients was hospitalized). The presence of severe TR (OR:
2.85; p¼0.03), TAPSE (p¼0.001), RVTei (p¼ 0,047) RVFAC (p¼ 0.049), ve sPAB
(0.04) was found signiﬁcant predictors for determining end point at univariate anal-
ysis. Other parameters was not found signiﬁcant; RV lat Sm (p¼0.32), RV diameter
(p¼0.15) PA diameter (p¼0.39) PV max (p¼0.06) ve RAAi (p¼0.169).The presence
of pericardial effusion tend to be higher, but not signiﬁcant (%62.5-%38.3 OR: 2,68
(0.97-7.40) p¼ 0.053). Cox regression analysis revealed 2 variables persisting the
prediction of primary endpoint; TAPSE <16.85 (HR: 3.17 p¼0.006) and RVTei
>0.49 (HR¼3.70; p¼ 0.02). on the other hand severe TR (p¼0.79) and sPAB>87
(p¼0.64) were not signiﬁcantly predictor at regression analysis (Table 1).
Conclusıon: This single center study revealed the importance of TAPSE and RVTei
index as echocardiographic markers for predicting prognosis. Other parameters did not
make an additional beneﬁt in this issue.ERS C163
